COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Open or close the search fields display
460 Studies found for: LENALIDOMIDE AND every 28 days AND response

A similar map is available for all studies in

Click on the map below to show a more detailed map (when available) or search for studies (when map not available).

Map Legend
Region Name Number of Studies
World [map] 460
North America 315
United States 306 [studies]
Alabama 28 [studies]
Alaska 8 [studies]
Arizona 51 [studies]
Arkansas 21 [studies]
California 104 [studies]
Colorado 42 [studies]
Connecticut 35 [studies]
Delaware 12 [studies]
District of Columbia 17 [studies]
Florida 96 [studies]
Georgia 55 [studies]
Hawaii 9 [studies]
Idaho 13 [studies]
Illinois 79 [studies]
Indiana 47 [studies]
Iowa 28 [studies]
Kansas 31 [studies]
Kentucky 32 [studies]
Louisiana 30 [studies]
Maine 11 [studies]
Maryland 63 [studies]
Massachusetts 62 [studies]
Michigan 61 [studies]
Minnesota 74 [studies]
Mississippi 12 [studies]
Missouri 64 [studies]
Montana 15 [studies]
Nebraska 33 [studies]
Nevada 17 [studies]
New Hampshire 10 [studies]
New Jersey 57 [studies]
New Mexico 13 [studies]
New York 121 [studies]
North Carolina 69 [studies]
North Dakota 15 [studies]
Ohio 89 [studies]
Oklahoma 16 [studies]
Oregon 30 [studies]
Pennsylvania 57 [studies]
Rhode Island 3 [studies]
South Carolina 38 [studies]
South Dakota 21 [studies]
Tennessee 49 [studies]
Texas 98 [studies]
Utah 19 [studies]
Vermont 7 [studies]
Virginia 29 [studies]
Washington 56 [studies]
West Virginia 16 [studies]
Wisconsin 45 [studies]
Wyoming 9 [studies]

Click on a [map] link to show a map of that region.

Click on a [studies] link to search within your current results for studies in that region. Use the back button to return to this list and try another region.

Studies with no locations are not included in the counts or on the map.

Studies with multiple locations are included in each region containing locations.